1. Publication
- Title: Restrictive vs Liberal Physical Restraint Strategies in Critically Ill Patients: The R2D2-ICU Randomized Clinical Trial
- Acronym: R2D2-ICU
- Year & Journal: JAMA, epublished March 17, 2026 (2026;335(14):1232-1242)
- Citation: Sonneville R, Couffignal C, Sigaud F, et al; R2D2-ICU Investigator Study Group. Restrictive vs Liberal Physical Restraint Strategies in Critically Ill Patients: The R2D2-ICU Randomized Clinical Trial. JAMA. 2026;335(14):1232-1242. doi:10.1001/jama.2026.2897
2. Context & Rationale
Background: ~41.6% of ICU patients are exposed to physical restraint (high between-study heterogeneity), used to prevent self-extubation and device removal, but the rationale has always been largely inferential. Adverse-event literature links restraint with skin injury, subsequent delirium, neurofunctional impairment, and PTSD symptoms. Until 2026, restraint use had never been examined in a randomized trial.
Research Question/Hypothesis: In mechanically ventilated ICU adults, does a restrictive (low-use) wrist-strap restraint strategy increase days alive without delirium or coma over 14 days, compared with a liberal (high-use) strategy?
Why This Matters: A rigorous trial was needed before routine prophylactic restraint could be defended as standard care; restraint restricts autonomy and may worsen distress despite being normalized in practice.
3. Design & Methods
- Study Type: Institutionally sponsored, multicenter, open-label, parallel-group, randomized superiority trial
- Setting & Centers: 10 ICUs, France
- Population:
- Inclusion: Adults ventilated <6h at screening, expected to need ventilation β₯48h, eligible for restraint prescription (not already restrained, no pre-existing prescription)
- Exclusions: Delirium before admission, dementia, anticipated alcohol withdrawal, primary neurological admission, major visual/auditory impairment, pregnancy/lactation, SAPS II >65, DNR order
- Intervention: Restrictive strategy β 2-point wrist straps only for severe agitation (RASS β₯3)
- Comparator: Liberal strategy β wrist straps applied systematically from day 0, reassessed daily
- Blinding: Open-label; primary outcome depended on structured RASS/CAM-ICU assessments (partly standardized, not fully blinded)
- Statistical Power & Follow-Up: 422 patients needed to detect 1-day increase in delirium/coma-free days (SD 3 days, 90% power). Primary endpoint at 14 days; additional outcomes to day 90.
4. Key Results
405 randomized; 396 in primary analysis (196 low-use, 200 high-use).
Outcome | Low-Use (Restrictive) | High-Use (Liberal) | Effect Size | 95% CI | p-value |
Days alive without delirium/coma at 14d (primary) | Mean 6.67d | Mean 6.30d | Adjusted mean diff 0.37d | β0.71 to 1.46 | 0.51 |
Delirium incidence at 14d | 122/196 (62.2%) | 135/200 (67.5%) | Adjusted RR 0.92 | 0.80β1.07 | β |
Self-extubation | 18/196 (9.2%) | 17/200 (8.5%) | Adjusted RR 1.11 | 0.59β2.07 | β |
Unplanned device removal | 2/196 (1.0%) | 1/200 (0.5%) | Adjusted RR 2.17 | 0.21β22.09 | β |
Pressure ulcers | 30/196 (15.3%) | 34/200 (17.0%) | Adjusted RR 0.90 | 0.56β1.42 | β |
ICU mortality | 51/196 (26.0%) | 58/200 (29.0%) | Adjusted HR 0.96 | 0.66β1.40 | β |
90-day mortality | 73/196 (37.2%) | 82/200 (41.0%) | Adjusted RR 1.00 | 0.72β1.40 | β |
Actual restraint time (dose check) | Median 0h (IQR 0β1.4) | Median 16.8h (IQR 10.3β23.6) | β | β | Strong intervention separation achieved |
Sedative use: No compensatory increase in chemical sedation with restrictive restraint (sufentanil, propofol, midazolam, antipsychotic, dexmedetomidine doses all similar between arms).
5. Internal Validity Assessment
- Randomization & Allocation: Central, computer-generated, variable block sizes, stratified by site/age/coma status β sound concealment.
- Protocol Adherence & Separation: Substantial nonadherence in both directions: 33.7% of low-use patients restrained β₯4 consecutive hours without severe agitation; 28.5% of high-use patients had restraints removed outside protocol β yet actual restraint-time separation remained large (0h vs 16.8h median).
- Missing Data: 9/405 excluded post-randomization; 14.1% had β₯1 missing primary-outcome assessment; only 180/396 (45%) completed formal day-90 follow-up.
- Blinding & Detection Bias: Open-label; bedside nurses knew allocation, a genuine concern since the primary outcome depends on RASS/CAM-ICU assessment rather than a hard endpoint.
- Overall Internal Validity Conclusion: Moderate β good randomization and real treatment separation, but open-label assessment, sample size below target (396 vs 422 planned), substantial nonadherence, and incomplete long-term follow-up limit confidence in ruling out smaller true effects. Weighted per-protocol analysis (1.07d, 95% CI β0.12 to 2.19, P=0.055) trended toward benefit while standard per-protocol trended oppositely, illustrating how contamination complicated causal inference.
6. External Validity Assessment
- Population Representativeness: General adult medical ICU population, respiratory failure predominant, 87-88% comatose at randomization β less transferable to more awake, behaviorally active agitation populations where restraint decisions are most debated.
- Practice Context: Participating centers were relatively restraint-intensive at baseline (75-100% restraint at ventilation initiation); routine delirium-scale use existed in only 5/10 centers.
- Overall External Validity Conclusion: Moderate β highly relevant to general ICUs with similar restraint practices and staffing, much less generalizable to units already using restraint sparingly or to high-risk agitation populations (neurological, alcohol withdrawal, dementia) that were excluded.
7. Strengths & Limitations
Strengths:
- First multicenter RCT directly comparing restraint strategies in ventilated ICU patients
- Real, substantial restraint-time separation despite protocol nonadherence
- Protocolized co-interventions (sedation, delirium screening, weaning, mobilization) in both arms
- No compensatory chemical-sedation escalation with restrictive strategy
Limitations:
- Open-label, unblinded primary-outcome assessment
- Sample size below target (396 vs 422)
- Substantial bidirectional nonadherence
- ~87% comatose at randomization, potentially diluting any delirium-specific effect
- Incomplete day-90 follow-up (45%)
- High-risk agitation populations excluded
8. Interpretation & Practice Impact
- Clinical Implications: Does not support routine prophylactic wrist restraint to improve delirium/coma outcomes; reducing restraint use produced no penalty in self-extubation, device removal, pressure injury, or mortality.
- Mechanistic Coherence: The safety-neutral result (no more self-extubation with less restraint) is the trial's most clinically useful and actionable signal.
- Systems-Level Takeaway: Clinicians in similar ICUs can reasonably move away from universal prophylactic restraint toward reserving it for clearly justified, short-duration severe agitation.
9. Controversies & Subsequent Evidence
- Editorial Commentary: Accompanying JAMA editorial (Haines, Nørregaard Kjær, Deane) notes the trial tested a predominantly deeply-comatose population, making it less informative for the agitation-prone patients in whom restraint is most often defended, and flags the unblinded primary outcome as a key limitation.
- Guideline Integration: No formal guideline update yet incorporates R2D2-ICU; the PADIS framework remains dominant. The result contradicts a 2025 meta-analysis of guide-based restraint-reduction interventions that had suggested lower delirium and unplanned extubation with restriction β R2D2-ICU, as a more direct head-to-head test, tempers that optimism.
10. Summary & Executive Takeaway
Summary: R2D2-ICU randomized 405 mechanically ventilated French ICU patients to restrictive (low-use) or liberal (high-use) wrist restraint. Days alive without delirium/coma at 14 days were not significantly different (6.67 vs 6.30 days, P=0.51), and self-extubation, device removal, pressure ulcers, and mortality were all similar between arms.
Overall Takeaway: Routine liberal wrist restraint confers no measurable delirium, coma, or safety advantage over a restrictive strategy in mechanically ventilated ICU patients β a landmark negative trial pushing practice toward restraint minimization, though its applicability to the most agitation-prone patients (largely excluded here) remains untested.
11. Bibliography
- Berger S, Grzonka P, Amacher SA, et al. Adverse events related to physical restraint use in ICUs. J Intensive Med. 2023;4(3):318-325.
- Haines KJ, Nørregaard Kjær MB, Deane AM. Physical restraint use in critical care: balancing safety and harm [editorial]. JAMA. 2026.